PriceTargets.com logo

Versigent - VGNT Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $45.67
  • Forecasted Upside: 11.67%
  • Number of Analysts: 11
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 7 Buy Ratings
  • 1 Strong Buy Ratings
$40.90 As of 05/21/2026 03:55 PM ET
▼ -1.694 (-3.98%)

This chart shows the closing price for VGNT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Versigent Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VGNT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VGNT

Analyst Price Target is $45.67
▲ +11.67% Upside Potential
This price target is based on 11 analysts offering 12 month price targets for Versigent in the last 3 months. The average price target is $45.67, with a high forecast of $60.00 and a low forecast of $28.00. The average price target represents a 11.67% upside from the last price of $40.90.

This chart shows the closing price for VGNT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 11 polled investment analysts is to moderate buy stock in Versigent.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/24/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/25/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/23/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/21/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/19/2026
  • 1 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
4/20/2026
  • 1 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
5/20/2026

Latest Recommendations

  • 1 strong buy ratings
  • 7 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
5/18/2026EvercoreReiterated RatingOutperform ➝ Outperform$60.00
5/8/2026Morgan StanleyInitiated CoverageOverweight$51.00
5/7/2026Deutsche Bank AktiengesellschaftReiterated RatingHold ➝ Hold$38.00
5/6/2026UBS GroupBoost TargetBuy ➝ Buy$43.00 ➝ $49.00
5/6/2026TD CowenBoost TargetBuy ➝ Buy$47.00 ➝ $49.00
5/6/2026Wells Fargo & CompanyBoost TargetOverweight ➝ Overweight$35.00 ➝ $42.00
4/30/2026Wolfe ResearchInitiated CoverageOutperform$53.00
4/28/2026BNP Paribas ExaneInitiated CoverageOutperform$41.00
4/28/2026Deutsche Bank AktiengesellschaftInitiated CoverageHold$35.00
4/21/2026EvercoreInitiated CoverageOutperform$55.00
4/16/2026Zacks ResearchUpgradeHold
4/14/2026TD CowenInitiated CoverageBuy$47.00
4/14/2026UBS GroupInitiated CoverageBuy$43.00
4/14/2026UBS GroupInitiated CoverageBuy$43.00
4/14/2026TD CowenInitiated CoverageBuy$47.00
4/7/2026Fox AdvisorsUpgradeStrong-Buy
4/6/2026Wells Fargo & CompanyInitiated CoverageOverweight$35.00
3/31/2026Royal Bank Of CanadaInitiated CoverageSector Perform$28.00
(Data available from 5/21/2021 forward)

News Sentiment Rating

0.28 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/23/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/22/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/22/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/21/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/20/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/22/2026
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/21/2026
  • 3 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
5/21/2026

Current Sentiment

  • 3 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Versigent logo
Read More

Today's Range

Now: $40.90
Low: $41.01
High: $42.59

50 Day Range

MA: N/A

52 Week Range

Now: $40.90
Low: $26.34
High: $47.27

Volume

1,203,894 shs

Average Volume

2,891,515 shs

Market Capitalization

$2.90 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Versigent?

The following equities research analysts have issued reports on Versigent in the last year: BNP Paribas Exane, Deutsche Bank Aktiengesellschaft, Evercore Inc, Fox Advisors, Morgan Stanley, Royal Bank Of Canada, TD Cowen, UBS Group AG, Wall Street Zen, Wells Fargo & Company, Wolfe Research, and Zacks Research.
View the latest analyst ratings for VGNT.

What is the current price target for Versigent?

0 Wall Street analysts have set twelve-month price targets for Versigent in the last year. Their average twelve-month price target is $45.67, suggesting a possible upside of 7.0%. Evercore Inc has the highest price target set, predicting VGNT will reach $60.00 in the next twelve months. Royal Bank Of Canada has the lowest price target set, forecasting a price of $28.00 for Versigent in the next year.
View the latest price targets for VGNT.

What is the current consensus analyst rating for Versigent?

Versigent currently has 3 hold ratings, 7 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for VGNT.